Literature DB >> 9182821

T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas.

M A Lowes1, G A Bishop, K Crotty, R S Barnetson, G M Halliday.   

Abstract

Spontaneous tumor regression, which is observed clinically and histologically in some primary melanomas, occurs in the absence of any effective therapy. It is probably immunologically mediated, because regressing melanomas are infiltrated with larger numbers of activated T cells, primarily CD4+, than nonregressing melanomas. To investigate the hypothesis that spontaneous regression of melanomas is caused by T-cell cytokine production, cytokine mRNA expression in 20 primary melanomas was examined using a noncompetitive, quantitative reverse-transcriptase polymerase chain reaction method. DNA standards were used to generate known numbers of molecules in each sample. Results were standardized to the internal control, glyceraldehyde-3-phosphate dehydrogenase. mRNA for CD35, lymphotoxin (TNF-beta), and IL-2 were significantly elevated in the ten regressing melanomas compared to the ten nonregressing melanomas. IFN-gamma mRNA was also elevated in regressing melanomas but failed to reach statistical significance. The Th2 cytokines IL-10 and IL-13 did not show differences in the regressing melanomas compared to nonregressing melanomas; neither did the pro-inflammatory cytokines IL-1alpha, IL-1beta, IL-6, IL-8, and TNF-alpha, nor the growth factors, bFGF and TGF-beta or GM-CSF. This study shows an association between Th1 cytokines and spontaneously regressing melanomas. Although we have not shown that these cytokines cause regression, these findings support our hypothesis that activated CD4+ T cells may mediate melanoma regression by secretion of Th1 cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182821     DOI: 10.1111/1523-1747.ep12292705

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

Review 3.  An association between corticosteroid use and melanoma recurrence: a case report and review of the literature.

Authors:  Mark Lazarus; Howard Kaufman
Journal:  Med Oncol       Date:  2011-09-16       Impact factor: 3.064

Review 4.  TGFβ in T cell biology and tumor immunity: Angel or devil?

Authors:  Eric Tu; Pei Zhi Cheryl Chia; Wanjun Chen
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

Review 5.  Immunotherapy for melanoma: the good, the bad, and the future.

Authors:  Christian H Poehlein; Dominik Rüttinger; Jun Ma; Hong-Ming Hu; Walter J Urba; Bernard A Fox
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

6.  Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.

Authors:  Kar Wai Tan; Maximilien Evrard; Muly Tham; Michelle Hong; Caleb Huang; Masashi Kato; Armelle Prevost-Blondel; Emmanuel Donnadieu; Lai Guan Ng; Jean-Pierre Abastado
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

7.  Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.

Authors:  Paul Greaves; Andrew Clear; Andrew Owen; Sameena Iqbal; Abigail Lee; Janet Matthews; Andrew Wilson; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

8.  Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.

Authors:  Nikolaos Koufos; Despina Michailidou; Ioannis D Xynos; Periclis Tomos; Kalliopi Athanasiadou; Christos Kosmas; Nikolaos Tsavaris
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

9.  Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.

Authors:  Catriona H T Miller; Laura Graham; Harry D Bear
Journal:  BMC Immunol       Date:  2010-11-04       Impact factor: 3.615

10.  Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.

Authors:  Lazar Vujanovic; Theresa L Whiteside; Douglas M Potter; Jessica Chu; Soldano Ferrone; Lisa H Butterfield
Journal:  Cancer Immunol Immunother       Date:  2008-05-17       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.